These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Datapoints: trends in combined pharmacotherapy with stimulants for children. Bhatara VS; Feil M; Hoagwood K; Vitiello B; Zima B Psychiatr Serv; 2002 Mar; 53(3):244. PubMed ID: 11875215 [No Abstract] [Full Text] [Related]
5. Management of psychopharmacologic agents in children and adolescents. Carlson GA; Ranade L; Qadir A Psychiatr Q; 1992; 63(4):391-411. PubMed ID: 1361998 [No Abstract] [Full Text] [Related]
6. Pharmacotherapy of attention deficit hyperactivity disorder. Spencer T; Biederman J; Wilens T Child Adolesc Psychiatr Clin N Am; 2000 Jan; 9(1):77-97. PubMed ID: 10674191 [TBL] [Abstract][Full Text] [Related]
7. Atomoxetine and stimulants in combination for treatment of attention deficit hyperactivity disorder: four case reports. Brown TE J Child Adolesc Psychopharmacol; 2004; 14(1):129-36. PubMed ID: 15142400 [TBL] [Abstract][Full Text] [Related]
9. Review of pharmacotherapy options for the treatment of attention-deficit/hyperactivity disorder (ADHD) and ADHD-like symptoms in children and adolescents with developmental disorders. Rowles BM; Findling RL Dev Disabil Res Rev; 2010; 16(3):273-82. PubMed ID: 20981766 [TBL] [Abstract][Full Text] [Related]
14. The adult psychiatrist's dilemma: psychostimulant use in attention deficit/hyperactivity disorder. Ashton H; Gallagher P; Moore B J Psychopharmacol; 2006 Sep; 20(5):602-10. PubMed ID: 16478756 [TBL] [Abstract][Full Text] [Related]
15. Modafinil for the treatment of attention-deficit/hyperactivity disorder: A meta-analysis. Wang SM; Han C; Lee SJ; Jun TY; Patkar AA; Masand PS; Pae CU J Psychiatr Res; 2017 Jan; 84():292-300. PubMed ID: 27810669 [TBL] [Abstract][Full Text] [Related]